Lufart Wins ‘Pharma Product of the Year’ at West Africa Healthcare Excellence Awards
The award-winning medication is manufactured at the Entrance Pharmaceuticals and Research Center, a subsidiary of the Tobinco Group, and is widely distributed across West Africa
Lufart, a flagship product of Tobinco Pharmaceuticals Limited (TPL), has been adjudged ‘Pharmaceutical Product of the Year’ at the 2025 Ghana-West Africa Healthcare Excellence Awards.
According to the event organizers, KN Communications Group, Lufart stood out due to its Active Pharmaceutical Ingredient (API) purity and its adherence to good manufacturing practices in compliance with Food and Drug Authority (FDA) and World Health Organization (WHO) guidelines. The award-winning medication is manufactured at the Entrance Pharmaceuticals and Research Center, a subsidiary of the Tobinco Group, and is widely distributed across West Africa.
Lufart’s exceptional qualities include its ability to release active ingredients effectively within the body, its stability under various conditions, and its protective packaging, which prevents contamination and ensures potency. These attributes, along with clear dosage instructions and expiration details, make Lufart a trusted pharmaceutical product across the region.
Beyond this recognition, Tobinco Pharmaceuticals Limited was also honored as the ‘Indigenous Pharmaceutical Brand of the Year’, further cementing its leadership in the industry. The company boasts an impressive portfolio of products, including Foligrow, Entramol, Coldrilif, Dicnac and Blopen.
Lufart has consistently gained industry recognition, having previously won ‘Product of the Year’ at the Ghana International Product Awards and ‘Pharma Product of the Year’ at the Ghana Pharma Awards.
Speaking on behalf of the Executive Chairman of the Tobinco Group, Elder Dr. Samuel Amo Tobbin, a Managing Director at the Tobinco Pharmaceuticals Limited, Dr. Christopher Mensah, expressed gratitude to the organizers for recognizing their commitment to quality and professionalism.
He also extended appreciation to Ghanaians and West Africans for their unwavering support of the Tobinco brand.
Dr. Mensah reaffirmed the company’s dedication to prioritizing human health and maintaining high pharmaceutical standards for the benefit of Ghana and the broader African continent.
Ghana|Atinkaonline.com|Ebenezer Madugu
